April 2009; 15 years ago (2009-04) in Boulder, Colorado
Founder
Patrick Mahaffy
Headquarters
Boulder, Colorado
,
U.S.
Revenue
$165 Million(2020)
Number of employees
429
Clovis Oncology is an American pharmaceutical company which mainly markets products for treatment in oncology.[1] Clovis was founded in 2009 and is headquartered in Boulder, Colorado.[2] The company is a publicly traded company on NASDAQ under the symbol CLVS[3] and is in the NASDAQ Biotechnology Index[4] with several products in its product pipeline.[5] As of December 31, 2017, the company was not profitable and had incurred losses in each year since its inception in April 2009.[6] In December 2022, Clovis Oncology filed for Chapter 11 bankruptcy.[7]
^"Clovis Oncology: A Winning Or Losing Lottery Ticket?". Forbes. November 16, 2015. Retrieved January 4, 2016.
^"CLVS Profile". finance.yahoo.com.
^"Clovis Oncology Inc". www.marketwatch.com. Retrieved January 4, 2016.
^"Overview NBI". nasdaq.com. Retrieved January 4, 2016.
^"Clovis Oncology – Products & Companion Diagnostics". Clovisoncology.com. March 9, 2015. Archived from the original on March 9, 2015. Retrieved January 4, 2016.
^Clovis Oncology, Inc. Form 10-K for the fiscal year ended December 31, 2017.
^Singh, Vandana (December 12, 2022). "Clovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286". yahoo.com. Retrieved December 12, 2022.
ClovisOncology is an American pharmaceutical company which mainly markets products for treatment in oncology. Clovis was founded in 2009 and is headquartered...
up Clovis in Wiktionary, the free dictionary. Clovis may refer to: Clovis (given name), the early medieval (Frankish) form of the name Louis Clovis I (c...
factor receptor tyrosine kinase inhibitor. It was being developed by ClovisOncology as a potential treatment for non-small-cell lung cancer. In May 2016...
California. It was being developed by ClovisOncology until it was sold to Pharmaand GmbH (Pharma&) as part of Clovis's bankruptcy proceedings. In December...
Lucitanib (INN) is a drug that is being investigated by ClovisOncology in clinical trials for the treatment of advanced solid tumours including metastatic...
for osteoporosis, multiple sclerosis, PCSK9 cholesterol meds, and immuno-oncology therapies. In 2017 it issued a controversial draft report on PARP inhibitors...
services to broadcasting Bruce Anthony John Ponder, Head, Department of Oncology, University of Cambridge and Li Ka Shing Professor and director, Cancer...
Global Information
$165 Million(2020)